The latest release on CT-0508 (NCT 04660929 human primary anti-HER2-CAR-M) has stated a rapid egress of CT-0508 from peripheral blood and CAR mRNA detection in all tumor biopsies of the first two patients without reference to time points [165]. This evidence concerns the gene ERBB2 and neoplasm.